Tu D. Dan

发表

Twenty-five year results of the national cancer institute randomized breast conservation trial

N. Simone, K. Camphausen, Sharon Smith, 2012, Breast Cancer Research and Treatment.

What benefits could caloric restriction bring to cancer patients?

N. Simone, C. Wright, Tu D. Dan, 2014, Future oncology.

Dosimetric Comparisons of Simulation Techniques for Left-Sided Breast Cancer in the COVID-19 Era: Techniques to Reduce Viral Transmission and Respect the Therapeutic Ratio

N. Simone, A. Harrison, L. Doyle, 2021, Cureus.

Not so fast: dietary restriction improves chemotherapy-related toxicity

N. Simone, Tu D. Dan, 2015, Cell cycle.

Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model

N. Simone, M. Cristofanilli, D. Monti, 2018, Cell cycle.

Neutrophilia and post-radiation thrombocytopenia predict for poor prognosis in radiation-treated glioma patients

E. Maher, R. Timmerman, Z. Wardak, 2022, Frontiers in Oncology.

Targeted drug combinations: avant-garde oncology.

J. Palmer, Tu D. Dan, 2015, Annals of translational medicine.

Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: updated results of an institutional clinical management approach.

N. Hockstein, A. Raben, D. Raben, 2015, Oral oncology.

miR-21 is required for hematopoietic cell viability following radiation exposure

N. Simone, C. M. Eischen, T. Deangelis, 2020 .

Socioeconomic and demographic determinants of radiation treatment and outcomes in glioblastoma patients

R. Timmerman, Z. Wardak, T. Patel, 2022, Frontiers in Neurology.

Impact of CDKN2A/B, MTAP, and TERT Genetic Alterations on Survival in IDH Wild Type Glioblastomas

E. Maher, R. Timmerman, Z. Wardak, 2022, Discover Oncology.

Caloric restriction augments radiation efficacy in breast cancer

James B. Mitchell, N. Simone, K. Camphausen, 2013, Cell cycle.

MicroRNA-21 is Required for Hematopoietic Cell Viability After Radiation Exposure.

N. Simone, C. M. Eischen, T. Deangelis, 2019, International journal of radiation oncology, biology, physics.

Emerging drugs to replace current leaders in first-line therapy for breast cancer

S. Swain, M. Cox, Tu D. Dan, 2006, Expert opinion on emerging drugs.

Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies

A. Dicker, R. Den, J. Hoffman-Censits, 2017, American journal of clinical oncology.

Radioisotopes in management of metastatic prostate cancer

R. Den, Tu D. Dan, N. Williams, 2016, Indian journal of urology : IJU : journal of the Urological Society of India.

Radium-223 in Metastatic Castrate Resistant Prostate Cancer

R. Den, Tu D. Dan, N. Williams, 2016 .

Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better

James J. Evans, D. Andrews, V. Bar-ad, 2015, Journal of Neuro-Oncology.

Management of Stage I Lung Cancer with Stereotactic Ablative Radiation Therapy.

Tu D. Dan, N. Williams, 2017, Surgical oncology clinics of North America.

Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer.

Holly Ning, Charles B Simone, Arnaud Belard, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer

N. Simone, M. Mehta, J. Palazzo, 2016, Cell cycle.

microRNAs: The Short Link between Cancer and RT-Induced DNA Damage Response

N. Simone, A. Dicker, C. Wright, 2014, Front. Oncol..

miR-21 Plays a Dual Role in Tumor Formation and Cytotoxic Response in Breast Tumors

N. Simone, K. Camphausen, J. Savage, 2021, Cancers.

Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment

James J. Evans, D. Andrews, E. Blomain, 2018, Journal of Neuro-Oncology.

Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment

James J. Evans, D. Andrews, E. Blomain, 2018, Journal of Neuro-Oncology.

Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?

James J. Evans, Isabella Zhang, D. Andrews, 2018, Journal of Neuro-Oncology.

microRNA alterations driving acute and late stages of radiation-induced fibrosis in a murine skin model.

James B. Mitchell, N. Simone, K. Camphausen, 2014, International journal of radiation oncology, biology, physics.

Quality and Reporting Accuracy of Phase 1 Drug Radiation Clinical Trials.

B. Leiby, A. Dicker, Y. Lawrence, 2016, JAMA oncology.

Absence of Bone Marrow Toxicity in Elderly Patients Treated With Recombinant Human Thyroid-stimulating Hormone and Empirically Dosed Radioiodine for Thyroid Cancer

E. Mazzaferri, R. Amdur, Tu D. Dan, 2013, American journal of clinical oncology.

Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer

N. Simone, M. Mehta, J. Palazzo, 2016, Cell cycle.

The Influence of Health Insurance Policy on Radiation Oncology Physician SBRT/SABR Use Practices: A North American Survey.

Tu D. Dan, Hyun Kim, Jenny Guo, 2017, International journal of radiation oncology, biology, physics.